Combination Immunotherapy With Herceptin and the HER2 Vaccine NeuVax
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- COL (ret.) George E. Peoples, MD, FACS
Cancer Insight, LLC
Study Director - COL (ret.) George E. Peoples, MD, FACS
Cancer Insight, LLC
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
29 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Samuel Oschin Comprehensive Cancer Institute - Cedars Sinai Medical Center
Beverly Hills, California, United States
- Sarcoma Oncology Research Center, Llc
Santa Monica, California, United States
- St. Joseph Heritage Healthcare
Santa Rosa, California, United States
- Katzen Cancer Research Center, George Washington University
Washington D.C., District of Columbia, United States
- Sibley Memorial Hospital
Washington D.C., District of Columbia, United States
- University of Miami
Deerfield Beach, Florida, United States
- University of Miami
Kendall, Florida, United States
- University of Miami
Miami, Florida, United States
- Florida Cancer Research Institute
Plantation, Florida, United States
- University of Miami
Plantation, Florida, United States
- H. Lee Moffitt Cancer Center & Research Institute, Inc
Tampa, Florida, United States
- University of Hawaii Cancer Center
Honolulu, Hawaii, United States
- Franciscan Health Indianapolis
Indianapolis, Indiana, United States
- Memorial Hospital of South Bend
South Bend, Indiana, United States
- Cancer Center of Kansas
Wichita, Kansas, United States
- Medstar Health - Good Samaritan Hospital
Baltimore, Maryland, United States
- Medstar Health - Union Memorial Hospital
Baltimore, Maryland, United States
- Medstar Health - Weinberg Cancer Institute at Franklin Square
Baltimore, Maryland, United States
- the Valley Hospital
Paramus, New Jersey, United States
- Tisch Cancer Institute/icahn School of Medicine at Mount Sinai
New York, New York, United States
- North Shore Hematology Oncology Associates
The Bronx, New York, United States
- Legacy Health, Legacy Good Samaritan Medical Center
Portland, Oregon, United States
- Thomas Jefferson University - Kimmel Cancer Center
Philadelphia, Pennsylvania, United States
- University of Texas M.D. Anderson Cancer Center
Houston, Texas, United States
- Texas Oncology (cancer Care Centers of South Texas)
San Antonio, Texas, United States
- Virginia Cancer Specialists
Fairfax, Virginia, United States
- Providence Regional Medical Center
Everett, Washington, United States
- Swedish Cancer Institute
Seattle, Washington, United States
- Columbia St. Mary'S
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 21 May 2013
- Primary completion
- 28 Sept 2018
- Completion
- 28 Sept 2018
- Last update posted
- 2 Dec 2020
- Registered enrollment
- 275
- Registry id
- NCT01570036
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.